Cytokinetics
CYTK
#2487
Rank
โ‚ฌ6.51 B
Marketcap
46,77ย โ‚ฌ
Share price
-0.64%
Change (1 day)
-18.13%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): -5,24ย โ‚ฌ

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is -5,50ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,95ย โ‚ฌ a decrease over its 2024 EPS that were of -4,79ย โ‚ฌ.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,24ย โ‚ฌ-11.89%
2025-5,95ย โ‚ฌ24.14%
2024-4,79ย โ‚ฌ-3.49%
2023-4,97ย โ‚ฌ28.24%
2022-3,87ย โ‚ฌ50.18%
2021-2,58ย โ‚ฌ40.8%
2020-1,83ย โ‚ฌ
2018-1,78ย โ‚ฌ-24.12%
2017-2,34ย โ‚ฌ-776.32%
20160,35ย โ‚ฌ-139.18%
2015-0,88ย โ‚ฌ125.58%
2014-0,39ย โ‚ฌ-67.67%
2013-1,21ย โ‚ฌ-44.58%
2012-2,19ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
15,84ย โ‚ฌ-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-31,66ย โ‚ฌ 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
2,36ย โ‚ฌ-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-45,85ย โ‚ฌ 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-1,05ย โ‚ฌ-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA